Citation Impact

Citing Papers

Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
1996 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Autopsy Proven Pulmonary Embolism in Hospital Patients: Are We Detecting Enough Deep Vein Thrombosis?
1989
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The Clinical Spectrum of Aspergillosis—Part 1: Epidemiology, Pathogenicity, Infection in Animals and Immunology of Aspergillus
1980
The Clinical Spectrum of Aspergillosis–Part 2: Classification and Description of Saprophytic, Allergic, and Invasive Variants of Human Disease
1980
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Endovascular Stent–Graft Placement for the Treatment of Acute Aortic Dissection
1999 Standout
Prevention of Deep Vein Thrombosis after Elective Hip Surgery
1991
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Glutathione disulfide production during arachidonic acid oxygenation in human platelets
1990
Chronic Venous Disease
2006 Standout
Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke
1994 Standout
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients
1988
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
1990
Nonsurgical Reconstruction of Thoracic Aortic Dissection by Stent–Graft Placement
1999 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Venous Claudication in Iliofemoral Thrombosis
2003
The Clinical Course of Pulmonary Embolism
1992 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
1992 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Venous ulceration: A cross-over study from nonoperative to operative treatment
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Leg Ulcers: Economic Aspects
2000
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
1979 StandoutNatureNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
2011 StandoutNobel
Leukotriene B4 is a complete secretagogue in human neutrophils: A kinetic analysis
1982 StandoutNobel
Open mitral commissurotomy
1980
Noninvasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease
1973
Aortic disease associated with pregnancy
1988
Effects of Intermittent Sequential Compression in Venous Hypertensive Microangiopathy
1994
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Endovenous thermal ablation for healing venous ulcers and preventing recurrence
2013 StandoutNobel
Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets
1976 StandoutNobel
Platelet Function
1969
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Complement Activation during Cardiopulmonary Bypass
1981 Standout
The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke
1992 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Aortic dissections and dissecting aneurysms
1972
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study.
1999
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
1976 StandoutNatureNobel
Plasma heparin levels after administration of calcium and sodium salts of heparin
1976
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
The Platelet-Stimulating Effect of Adrenaline Through α2-Adrenergic Receptors Requires Simultaneous Activation by a True Stimulatory Platelet Agonist
1993
Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin-Induced Skin Necrosis
1979
Vascular Status of Patients Who Have Cholesterol Emboli in the Retina
1966
Enzyme Release from Polymorphonuclear Leukocyte Lysosomes: Regulation by Autonomic Drugs and Cyclic Nucleotides
1973 StandoutScienceNobel
The Role of Fibrin Monomer and an in vivo Thrombin‐Induced Anticoagulant in Experimental Venous Thrombosis
1974
Cutaneous reactions secondary to heparin injections
1985
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
1977
A Cost-effectiveness Analysis of Prophylaxis Against Deep-Vein Thrombosis in Major Orthopedic Surgery
1987
Warfarin-induced skin necrosis
1986
Observations on the change in shape of blood platelets brought about by adenosine diphosphate
1970
EXTRACELLULAR CYCLIC NUCLEOTIDES*
1971 StandoutNobel
Use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open-heart surgery
1978
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
1987 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
β-Adrenergic receptors in human platelets
1969
Inhibitory effects of the D(−) isomer of 3-hydroxybutyrate on cardiac non-esterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog
1985
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout

Works of Michael Hume being referenced

Mitral valvulotomy
1969
Consensus Paper on Venous Leg Ulcers
1992
Surgical Management of Cerebrovascular Insufficiency
1963
Sex, Aspirin, and Venous Thrombosis
1978
125I Fibrinogen and the Prevention of Venous Thrombosis
1973
Prevention and early detection of peripheral vascular disease.
1970
Prediction of myocardial O2 requirements by indirect indices
1982
Presidential address: A venous renaissance?
1992
Venous Thrombosis: Mechanisms and Treatment
1978
Dissecting Aneurysm in Pregnancy Associated with Aortic Insufficiency
1963
The Laboratory Diagnosis of Venous Thromboembolic Disease by Measurement of Fibrinogen/Fibrin Degradation Products and Fibrin Monomer
1973
Extent of leg vein thrombosis determined by impedance and 125I fibrinogen
1975
Blood Tests and Doppler Flowmeter Examination
1968
Treatment of pulmonary aspergillosis with di-iodohydroxyquinoline.
1977
Effects of the Numbers and Sizes of Platelet Aggregates on the Optical Density of Plasma
1967 Nature
SENSITIVITY TO INTRAFAT HEPARIN
1974
Venous ulcers, the vascular surgeon, and the Medicare budget
1992
Acute venous thrombosis.
1983
Rankless by CCL
2026